By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
.
In order to undertake qualitative and/or quantitative examinations of the morphology of the blood, its constituent parts, and blood-forming tissues, haematology reagents are substances or chemicals. These reagents are those that are employed in haematology assays such as control and calibration, blood cell counts, and coagulation testing.
The substances or chemicals known as haematology reagents are designed to perform qualitative and/or quantitative examinations of the morphology of the blood, its constituent parts, and blood-forming tissues. Among these reagents are those employed in blood cell counts, coagulation testing, further haematology examinations, control, and calibration.
Automated haematology analyzers can quickly perform a complete blood count on samples of whole blood (CBC). Results include a leukocyte differential, haemoglobin concentration, hematocrit, platelet count, white blood cell (WBC) count, and red blood cell (RBC) count.
The study of blood cells and coagulation is covered by haematology. For the typical physiological symptoms, such as infections, anaemia, autoimmune disorders, diabetes, and cancer, blood testing is crucial.
The study or examination of blood frequently exposes genetic information, organ abnormalities, infections, etc. Hematology analyzers, which can be basic handheld photo-optical equipment, cutting-edge diagnostic point-of-care instruments, highly automated or complex test facility analyzers, are frequently accessible to examine blood and blood-related concerns.
The Global Hematology Reagents market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The ProCyte One Hematology Analyzer was just introduced, according to IDEXX Laboratories, Inc., a leader in veterinary diagnostics and software.
The cutting-edge technology in the new analyzer provides ground-breaking workflow simplicity and reliable, accurate results at the point of care. Pre-orders for the ProCyte One Hematology Analyzer are currently being taken in North America; later this year, pre-orders will also be taken in a few European areas.
The President and Chief Executive Officer of IDEXX Laboratories stated that “ProCyte One reimagines point-of-care haematology with a radically streamlined workflow that almost removes complexity without losing performance.” Making something simple can sometimes increase capabilities and push the boundaries of what is achievable.
